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Transcription is a highly dynamic process. Conse-
quently, we have developed native elongating
transcript sequencing technology for mammalian
chromatin (mNET-seq), which generates single-
nucleotide resolution, nascent transcription profiles.
Nascent RNA was detected in the active site of RNA
polymerase II (Pol II) along with associated RNA
processing intermediates. In particular, we detected
50splice site cleavage by the spliceosome, showing
that cleaved upstream exon transcripts are associ-
ated with Pol II CTD phosphorylated on the serine 5
position (S5P), which is accumulated over down-
stream exons. Also, depletion of termination factors
substantially reduces Pol II pausing at gene ends,
leading to termination defects. Notably, termination
factors play an additional promoter role by restricting
non-productive RNA synthesis in a Pol II CTD S2P-
specific manner. Our results suggest that CTD
phosphorylation patterns established for yeast tran-
scription are significantly different in mammals.
Taken together, mNET-seq provides dynamic and
detailed snapshots of the complex events underlying
transcription in mammals.INTRODUCTION
Virtually all transcripts synthesized by RNA polymerase II (Pol II)
from protein-coding genes are co-transcriptionally processed to
generate the final functional mRNA (Moore and Proudfoot, 2009).
First, a Cap structure (me7Gppp) is added to the transcript 50 end
soon after transcriptional initiation, which ultimately earmarks
transcripts for efficient cytoplasmic translation. Then as the
polymerase proceeds to elongate through the gene body (GB),
intronic RNA, which often constitutes the majority of the primary
transcript in mammalian genes, is removed by a splicing mech-
anism involving the stepwise assembly of a complex set of small526 Cell 161, 526–540, April 23, 2015 ª2015 The AuthorsRNA (snRNA) and associated proteins that together make up the
spliceosome (Wahl et al., 2009). In outline, U1snRNA-protein
complex (U1snRNP) identifies the intron 50 splice site (SS) as
soon as it is transcribed by Pol II, and then on reaching the 30
end of the intron multiple snRNPs, U2, U4, U5, and U6 recognize
the 30SS and proximal intronic branch point on the nascent tran-
script. Following reorganization of snRNP/intron interactions, the
branch point A nucleotide carries out a 20OH nucleophilic attack
on the 50SS, resulting in cleavage of the intron from the upstream
exon. The newly formed upstream exon 30OH then undergoes a
second nucleophilic attack on the 30SS, resulting in precise
fusion of adjacent exons and release of the intron. Prior to intron
splicing, hairpin structures embedded within some introns are
excised by the double-strand RNA-specific microprocessor
complex. This comprises an RNA-binding protein DGCR8
together with the endonuclease Drosha, which facilitate release
of pre-microRNA (miRNA) hairpins from the nascent transcript.
These pre-miRNA go on to form cytoplasmic miRNA, which
are critical for the translational regulation of many mRNA (Krol
et al., 2010). Finally at gene 30 ends, a further RNA-processing re-
action involving cleavage of the nascent transcript at a specific
poly(A) signal (PAS) occurs. This RNA cleavage reaction is medi-
ated by an endonuclease (CPSF73) that is part of a large multi-
meric cleavage and polyadenylation complex. A poly(A) tail is
then added to the mRNA 30 end, promoting rapid release of
mRNA from the chromatin template (Proudfoot, 2011). Although
these individual RNA-processing mechanisms are well charac-
terized, their interconnections with transcription remain enig-
matic. We describe in this study a method to investigate these
interconnections, genome wide.
The above outlined co-transcriptional pre-mRNA-processing
reactions are precisely coordinated with the Pol II transcription
cycle that proceeds from initiation at the transcription start site
(TSS), leading on to elongation through the GB and ending
with release of themRNA at the PAS, also called the transcription
end site (TES). Finally, termination occurs whereby Pol II sepa-
rates from the DNA template. Both the Pol II transcription cycle
and coupled pre-mRNA-processing reactions are orchestrated
by a unique structural feature of Pol II. This comprises an
extended C-terminal domain (CTD) of the large subunit (Rpb1)
that has a heptad structure YSPTSPS repeated 52 times with
some variation in mammals and 26 times in budding yeast. This
CTD is separate from the main globular enzyme, being posi-
tioned close to the RNA exit channel. It is relatively unstructured
(Meinhart and Cramer, 2004) and subject to extensive post-
translational modification, especially phosphorylation of S2
and S5 but also Y1, T4, and S7 (Heidemann et al., 2013; Hsin
and Manley, 2012). This combined but differential CTD phos-
phorylation is often considered to be a molecular code that
acts to orchestrate transcription and coupled pre-mRNA pro-
cessing. Especially in simpler eukaryotes, such as budding
yeast, CTD S5P is correlated with TSS-associated events,
whereas S2P is thought to correlate with TES events (Buratow-
ski, 2009). However in the larger and more complex genes of
mammals, this CTD code may be less clear-cut and vary be-
tween different gene classes.
To gain a more complete understanding of the Pol II transcrip-
tion cycle and how this is coordinated with co-transcriptional
pre-mRNA processing, genome-wide analysis of nascent RNA
has been undertaken. For example, global nuclear run on-
sequencing (GRO-seq) and precision nuclear run on-sequencing
(PRO-seq) with modified nucleotides (Core et al., 2008; Kwak
et al., 2013) provide a way to study Pol II profiles associated
with nascent transcription. Similarly, 50 capped nascent RNA
isolated from insoluble chromatin can be sequenced at high res-
olution (30NT-seq) (Weber et al., 2014). These approaches gener-
ated detailed maps of Pol II nascent transcription in mammals
and flies, which accumulates at promoters, providing a regulated
transition from initiation into productive elongation (Adelman and
Lis, 2012; Core and Lis, 2008; Gilchrist et al., 2010; Rahl et al.,
2010). Precise maps of PRO-seq reads identified two different
types of Pol II pausing at the TSS, referred to as proximal and
distal TSS pausing. PRO-seq additionally showed Pol II accumu-
lation near 30SS, possibly important for the selection of active
exons (Kwak et al., 2013). GRO-seq has also shown a correlation
between Pol II density and nucleosome occupancy as observed
at the TES of many genes, suggesting a connection with tran-
scription termination (Grosso et al., 2012). A significant limitation
to these above nascent RNA-mapping techniques is that the
relationship between Pol II CTD modification and nascent RNA
was not established.
Precise maps of Pol II nascent RNA have also been generated
by native elongating transcript sequencing (NET-seq) in yeast
(Churchman and Weissman, 2011). Here, endogenous Pol II is
flag tagged by genomic integration allowing immunoprecipita-
tion (IP) of Pol II nascent RNA complexes. However, again con-
nections between Pol II CTD modifications and nascent RNA
could not be determined. In contrast, we establish mammalian
NET-seq technology (mNET-seq) using a selection of CTD phos-
phorylation-specific Pol II antibodies to IP Pol II-associated tran-
scripts. In detail, we have compared low or unphosphorylated
(unph), S2P, S5P, and total (unph+ph) CTD mNET-seq profiles
and show that unph CTD Pol II-nascent RNA are accumulated
over the TSS, whereas S2P Pol II-nascent RNA are spread
throughout the GB and TES. Remarkably S5P profiles precisely
correlate with active splicing on protein-coding genes. An impor-
tant feature of our analysis is that we are able to directly detect
the initial 50SS cleavage step in intron splicing and can also
observe active Drosha cleavage of pre-miRNA hairpin structurespresent in gene introns. In effect, our extensive mNET-seq data
sets provide a ‘‘treasure trove’’ of detailed information on
nascent transcription and co-transcriptional RNA processing in
mammalian cells.
RESULTS
mNET-Seq Strategy
To detect unstable nascent RNA across the human genome, we
isolated a nuclear chromatin fraction from HeLa cells enriched in
transcriptionally active Pol II (Pol IIo) and associated nascent
RNA (Figure 1A) (Nojima et al., 2013). This chromatin-bound
RNA was fragmented to 150–200 nt and ligated to adaptors for
strand-specific paired-end deep sequencing (Figure S1A, top;
Experimental Procedures). ChrRNA-seq detects unstable RNA,
such as promoter upstream transcripts (PROMPTs), introns,
and read-through transcripts (Figures 1D and S1B). For mNET-
seq, chromatin was digested with micrococcal nuclease
(MNase) to release Pol II from insoluble chromatin. Note that
accessible RNA will also be digested (Figure S1A, bottom;
Experimental Procedures). Western blot analysis using Pol II
8WG16 antibody confirmed that both phosphorylated (Pol IIo)
and unphosphorylated (Pol IIa) forms were released in a MNase
dose-dependent manner (Figure 1B). Nascent RNA distribution
was also tested after cell fractionation and MNase digestion,
by using nuclear run on (NRO) nuclei, labeled with [a-32P] UTP
(Figure 1C). The nucleoplasmic (Np) fraction contained long
32P-RNA (over 600 nt). However, after MNase digestion
(40 U/ml), the residual chromatin pellet (P) contained RNA of
10–600 nt, whereas the chromatin supernatant (S) had shorter
RNA of 10–200 nt. This supernatant fraction was then IPed using
Pol II 8WG16 antibody, which efficiently precipitated this shorter
RNA. Although the predominant size of the IPed RNA was 20–
45 nt, we selected a longer RNA fraction (35–100 nt) to
obtain unique alignment with the human genome after deep
sequencing. In this method, the Pol II complex will protect
nascent RNA from MNase digestion. The hydroxylated 30 end
(30OH) of the nascent RNA corresponds to the terminal nucleo-
tide synthesized by Pol II (Figure 1A, asterisk). The 50 end of
the cleaved Pol II-associated RNA is also hydroxylated after
MNase digestion. To achieve strand-specific RNA sequencing,
we carried out a kinase reaction on the IP beads to phosphory-
late all nascent RNA 50 ends but leave the Pol II-embedded
30OH intact (Figure S1A). Illumina adapters were then ligated
onto gel-purified RNA, and Illumina high-throughput paired-
end sequencing was carried out and generated 108 reads for
each mNET-seq sample. For library construction, we omitted
the NRO step because the NRO reaction may perturb the native
Pol II distribution. The above Pol II IP from MNase-treated chro-
matin coupled with isolation and sequencing of the associated
RNA constitutes a refined mammalian NET-seq protocol.
Finally, libraries were prepared from two biological replicates
of HeLa native chromatin after Pol II 8WG16 IP. Deep sequencing
was conducted using a reverse sequence primer to read the 30
ends of the RNA insert, which corresponds to the RNA synthesis
site in the Pol II active site (Figure 1A). mNET-seq data aligned to
the human genome (hg19) was compared to 8WG16 chromatin
IP (ChIP-seq) and ChrRNA-seq as shown for ATP5G1, a typicalCell 161, 526–540, April 23, 2015 ª2015 The Authors 527
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Figure 1. mNET-Seq Methodology
(A) ChrRNA-seq and mNET-seq strategies. Pol II (blue) elongating complex (gray circle) and associated nascent RNA (red line) in chromatin. Orange asterisk
depicts the 3’OH of nascent RNA. For ChrRNA-seq (top), fragmented nascent RNA is subjected to directional paired-end deep sequencing. For mNET-seq
(bottom), DNA and RNA are digested with MNase and Pol II-nascent RNA complex precipitated with Pol II antibody. Isolated RNA is deep sequenced, and the 30
end nucleotide uniquely mapped on the human genome.
(B) Pol II release from insoluble chromatin DNA. Chromatin DNA was digested with increasing amounts of MNase. Western blot used 8WG16 Pol II antibody.
P; pellet, S; supernatant. IIo and IIa indicate phosphorylated and unphosphorylated Pol II.
(C) Nascent RNA distribution in mNET-seqmethod. Nascent RNA was 32P-labeled by NRO reaction. Fractionated nascent RNA are nucleoplasm (Np), chromatin
pellet (Chr (P)) and supernatant (Chr (S)). IP was with 8WG16 Pol II antibody. 35–100 nt RNA purified from gel (red box). IPed Pol II was detected by western blot
(bottom).
(D) ATP5G1 mNET-seq. Two biological replicates of mNET-seq/unph using 8WG16 Pol II antibody. ChrRNA-seq shown as mNET-seq input. ChIP-seq (Pol II
[8WG16], H3K4m3, and H3K36m3) data are from ENCODE project data sets (Consortium et al., 2012).example of an actively expressed gene in HeLa cells (Figure 1D).
A lower-resolution cluster of genes expressed at varying levels is
also presented (Figure S1B). Note that as mNET-seq identifies
the 30 end of transcript within the Pol II active site, TSS-associ-
ated reads will only be detected 30 nt or beyond the exact
TSS. Modifications of histone H3, H3K4m3 and H3K36m3,
reflect active promoters and gene bodies, respectively. Strand-
specific transcription activity was revealed by ChrRNA-seq. As
expected, both replicates of mNET-seq/8WG16 (unph) display
strong peaks at the active TSS, consistent with the previously
described ChIP-seq/unph profiles. We therefore predict that
this TSS-accumulated mNET-seq signal reflects Pol II pausing.
Additionally, mNET-seq data revealed both sense and antisense
transcription on active genes, as previously shown by GRO-seq
and PRO-seq (Core et al., 2008; Kwak et al., 2013).528 Cell 161, 526–540, April 23, 2015 ª2015 The AuthorsPol II CTD Phosphorylation-Specific Nascent RNA
Profiles at TSS and TES
A major benefit of our mNET-seq procedure is that it allows the
use of different Pol II antibodies to precipitate modified Pol II-
associated nascent transcripts. We elected to employ newly
described specific monoclonal antibodies to detect CTD phos-
phorylation-dependent nascent RNA profiles for S2P, S5P, and
all CTD isoforms (Figure 2A) (Stasevich et al., 2014). We carried
out further tests to confirm the specificity of these antibodies
versus 8WG16. First we performed ELISA assays (Figure S2A)
with synthetic peptides of 15 amino acids, containing two adja-
cent heptad repeats, either singly or doubly phosphorylated on
S2P, S5P, and S7P. As expected, 8WG16 bound with relative
specificity to unphosphorylated or singly phosphorylated CTD
peptides. CMA601 bound all CTD peptides with or without serine
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Figure 2. mNET-Seq with Different Phospho-CTD Modifications
(A) Diagram showing different Pol II antibody epitopes on CTD (Stasevich et al., 2014).
(B) Specificity of Pol II phosphorylation released from chromatin following MNase treatment with indicated Pol II antibodies.
(C) Meta-analyses of mNET-seq/unph+ph on TSS and TES of pA+ protein-coding genes (left) and histone genes (right). Read density (FPKM) of mNET-seq data
were plotted around TSS (±0.5 kb) and TES (0.5 k+3 kb). Data on pA+ and histone genes are represented as mean ± SEM. mNET-seq sense strand, blue;
antisense strand, red.
(D) Meta-analyses of mNET-seq on TSS and TES of pA+ protein-coding genes. Ratio of read density (FPKM) of indicated mNET-seq data to mNET-seq/
unph+ph data was plotted around TSS (±0.5 kb) and TES (0.5 k+3 kb). unph, dark gray; S2P, blue; S5P, red. Line and shading represent mean ± SEM for each
bin.
(E and F) mNET-seq profiles over TSS of TARDBP (E) and TES of CDK1 (F). Read density, read per 108 sequences.
Cell 161, 526–540, April 23, 2015 ª2015 The Authors 529
phosphorylation, whereas CMA602 and CMA603 bound CTD
peptides containing S2P and S5P, respectively. We also per-
formed IP Pol II western blots (Figure S2B) with these four
antibodiesundermNET-seqconditionsandconfirmed their spec-
ificity and IP efficiency. We finally performed Pol II ChIP analysis
on three specific genes comparing our monoclonal antibodies
to commercial polyclonal antibodies (ab5095 [S2P] and ab5131
[S5P], respectively) that are widely used for ChIP-seq assays
(Pe´rez-Lluch et al., 2011) (Figure S2C). Notably, matching ChIP
profileswereobserved for thedifferentS2P-andS5P-specifican-
tibodies. A potential concern with our mNET-seq protocol was
that, as we only partially solubilize the chromatin pellet byMNase
treatment, there may be selective release of different Pol II mod-
ifications. However, the chromatin pellet and supernatant
following MNase treatment gave very similar patterns of Pol IIo
and Pol IIa with all four antibodies arguing against selective
release of differentially modified Pol II (Figure 2B).
Based on previously published RNA-seq data (Lacoste et al.,
2014), we found 11,560 (45%) RefSeq genes actively transcribed
in HeLa cells. However, to avoid over-represention of ncRNA
(such as rRNA, tRNA, snoRNA, and snRNA) in the mNET-seq
meta-analysis, we excluded genes overlapping these se-
quences. We also excluded overlapping transcription units as
these might bias average profiles (see Extended Experimental
Procedures). We initially looked at meta-profiles over TSS and
TES regions for all Pol II isoforms (unph+ph antibody). As ex-
pected, bidirectional TSS mNET-seq peaks were detected and
a wider, mainly sense peak beyond the TES. In contrast, the his-
tone genes gave a flatter mNET-seq profile across these short
poly(A) minus genes and diminished TSS antisense reads
(Figure 2C). This clearly shows the specificity of our mNET-seq
profiles. We next analyzed meta-profiles using the CTD phos-
pho-specific Pol II antibodies (Figure 2D). To allow cross-com-
parison between the different antibodies, the data are presented
asa ratiowithmNET-seq readsobtained for total Pol II (unph+ph).
Remarkably, only mNET-seq/unph gave a bidirectional TSS pro-
file, whereas S2P andS5P show a gradual increase from low TSS
signals to higher signals in the GB. The TES meta-profiles re-
vealed the expected dominance of S2P. Single-gene TSS and
TES mNET-seq profiles (TARDBP and CDK1, respectively)
were consistent with the meta-profiles. The marked differences
in mNET-seq profiles observed for specific CTD phosphorylation
were not seen for histone genes, which showed little difference
other than higher unph reads across the genes (Figure S2D).
Overall, mNET-seq profiles reveal remarkable CTD phosphoryla-
tion specificity for poly(A)+ protein-coding genes.
Exon Tethering to Pol II with CTD S5P for
Co-Transcriptional Splicing
The coupling of Pol II transcription to splicing is well established
(Moore and Proudfoot, 2009). For example, altered Pol II elonga-
tion speed can affect alternative splicing patterns (Ip et al., 2011;
Mun˜oz et al., 2009), indicating that Pol II slows down near splice
sites to promote spliceosome assembly. In particular, genome-
wide analysis of nascent RNA by high-resolution tiling arrays
in yeast showed that Pol II is paused over terminal exons but
only for co-transcriptionally spliced genes (Carrillo Oesterreich
et al., 2010). Additionally, precisely timed ChIP analysis in yeast530 Cell 161, 526–540, April 23, 2015 ª2015 The Authorsrevealed that Pol II CTD S5P accumulates over the 30SS of
intron-containing genes (Alexander et al., 2010). Furthermore,
this splicing-dependent Pol II pausing requires pre-spliceosome
assembly (Chathoth et al., 2014).
We were interested to determine whether our mNET-seq pro-
files reflect the co-transcriptionality of splicing, but we observed
unexpected patterns. First, we present themNET-seq profile of a
specific gene, TARS, comparing the four different Pol II antibody
profiles (Figure 3A). Surprisingly, mNET-seq/S5P selectively de-
tected prominent exon peaks. We have reasoned that mNET-
seq will specifically identify the nascent transcript 30OH in the
Pol II active site. However, as previously noted (Churchman
and Weissman, 2011), co-precipitated spliceosomes contain
30OH RNA derived from splicing intermediates that also yield
NET-seq signal. Remarkably, single-nucleotide analysis of
TARS exon 9 reveals that the major S5P peaks exactly match
the 50SS (Figure 3A, lower panel). These observations suggest
that S5P detects the initial 50SS cleavage intermediate, indi-
cating that spliceosome complex C is associated with Pol II
CTD S5P. We next performed meta-analysis of mNET-seq
comparing all four antibodies over gene regions that are co-tran-
scriptionally spliced as judged by fused exon reads (Figure 3B).
As for TARS, these actively spliced introns give a strong 50SS
S5P-specific signal indicative of co-precipitated spliceosome
C complex. Significantly, we also detect selective accumulation
of S5P reads over the downstream exon. Apparently, Pol II CTD
S5P pauses over exon sequences and so allows time for the spli-
ceosome to perform the first catalytic step. This will generate
intronic lariats and cleaved upstream exons, which remain teth-
ered to the downstream positioned Pol II. To further substantiate
this mechanism, we carried out additional meta-analysis of pre-
dicted included or excluded exons from final spliced mRNA in
HeLa cells by analyzing total poly(A)+ RNA-seq data (Katz
et al., 2010). Again, we demonstrate a strong 50SS S5P signal
for included but not excluded exons (Figure 3C). We finally pre-
sent mNET-seq analysis for five intronless genes that show no
clear S5P peaks (Figure S3).
The surprising observation that mNET-seq/S5P profiles show
a strong 50SS signal merited further experimental validation. We
therefore employed the splicing inhibitor pladienolide B (Pla-B),
which is known to inactive the SF3b sub-complex of U2 snRNP
(Kotake et al., 2007), required for intronic branch point recogni-
tion as a prelude to the first catalytic step of intron splicing. We
initially confirmed the effect of Pla-B treatment on two specific
genes (BRD2 and BZW1). First, nucleoplasmic RNA from control
DMSO or Pla-B-treated cells was sequenced (NpRNA-seq), and
the patterns obtained across these two genes showed a clear
increase in intron retention (Figure 4A). This was confirmed by
RT-PCR with specific exon primers (Figure 4B) where Pla-B
treatment enhanced intron retention in both cases. Notably,
mNET-seq/S5P analysis across these same two genes showed
the usual high 50SS peaks for the control but not Pla-B-treated
cells (Figure 4A). To establish generality, we performed meta-
analysis over 1,051 actively spliced introns (Figure 4C). As
before, we saw the high 50SS peak and enrichment of S5P reads
over the downstream exon. Dramatically, Pla-B treatment
eradicated the 50SS signal and substantially reduced down-
stream exon pausing. These results confirm that the 50SS
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Figure 3. Exon Tethering to Ser5-Phosphorylated Pol II Complex
(A) TARS mNET-seq profile with different antibodies, followed by expanded view of exon 9 50SS. S5P-dominant peaks are indicated by black arrows.
(B) Meta-analysis of mNET-seq profiles over 30 ends (left) and 50 ends (right) of co-transcriptionally spliced exons. Single asterisk, peak at 30 end of spliced exon;
double asterisk, accumulation of Pol II at 50 end of spliced exon.
(C) Meta-analysis of mNET-seq data over 50SS of included exons (orange) and excluded exons (green).
For (B) and (C), bars represent mean ± SEM for each base.mNET-seq/S5P signal that we detect genome wide for spliced
exons is indeed a bona fide splicing intermediate.
We also studied the mutually exclusive exons 9 and 10 of
PKM. RT-PCR and ChrRNA-seq analyses show that exon 10 is
predominantly included in mature PKM transcripts in HeLa cells
(Figures S4A and S4B) (David et al., 2010). Furthermore the
mNET-seq/S5P profile gave the characteristic 50SS signal at
the end of exon 10 but not exon 9 of PKM (Figure S4B). To exper-
imentally manipulate this well-known case of alternative splicing,we performed S5P analysis on chromatin from cells with the
splicing-regulatory protein PTBP1 depleted by siRNA treatment
(Figure S4C), which is known to be required for the alternative
splicing of PKM exon 10 (David et al., 2010). As shown by a
lower-resolution and then single-nucleotide resolution mNET-
seq profile, the 50SS peak is reduced at the end of exon 10 but
enhanced at the end of exon 9 after depletion of PTBP1 (Fig-
ure S4E). Again, this splice-site switch is confirmed by RT-PCR
analysis (Figure S4D). Overall, these data on PKM exon 9 andCell 161, 526–540, April 23, 2015 ª2015 The Authors 531
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Co-Transcriptional Pre-miRNA Biogenesis
Most pre-miRNA are present within the introns of protein-coding
genes and are excised co-transcriptionally by the micropro-
cessor complex, containing Drosha and DGCR8 (Morlandoet al., 2008; Pawlicki and Steitz, 2008). Drosha cleavage gener-
ates 30OH ends that have the potential for mNET-seq detection.
Because RNA cleavage sites on pre-miRNA generated by the
microprocessor complex are quite variable, we individually
checked the mNET-seq profiles for highly expressed pri-miRNA
in HeLa cells. Our analysis began with PANK3, which harbors
hsa-mir-103a-1 in its penultimate intron (Figure 5A). Its mNET-
seq profiles show high S5P 50SS peaks indicative of exonCell 161, 526–540, April 23, 2015 ª2015 The Authors 533
tethering for each exon except exon 5, before the pre-miRNA-
containing intron 5. Instead a peak is detected with S5P- and
S2P-specific antibodies over the pre-miRNA within this intron.
The single-nucleotide resolution profile over hsa-mir-103a-1
(Figure 5A, bottom) shows twopeaks bymNET-seq/S2Pdefining
the pre-miRNA 50 and 30 ends. Notably, only the 50 end is de-
tected by mNET-seq/S5P. Similarly hsa-mir-27b in an intron of
C9orf3 gives S5P and S2P peaks at both ends of the pre-miRNA
(Figure 5B). In contrast, for intronic hsa-mir-26b (CTDSP1), only a
50 peak is detectable (Figure 5C). A further three examples of in-
tronic pre-miRNAs showboth 50 and 30 pre-miRNA peaks detect-
able by either mNET-seq/S5P or S2P (Figures S5A–S5C). These
specific 50 and 30 end pre-miRNA peaks correspond to the 30
ends of the cleaved intron and the pre-miRNA, which reaffirms
the co-transcriptionality of pre-miRNA processing. As with spli-
ceosomes, we suggest that microprocessor is co-precipitated
with Pol II so that 30OH intermediates of Drosha cleavage are de-
tected bymNET-seq. Two pre-miRNAs (hsa-mir181a-1 and hsa-
mir181b-1) are located in the MIR181A1HG intron (Figure 5D).
Although the ENCODE project data (Consortium et al., 2012)
show that both mature miRNAs are expressed in HeLa cells,
only hsa-mir181a-1 yields significant mNET-seq peaks. This cor-
relates with ChrRNA-seq analysis showing a signal window over
hsa-mir181a-1, but not hsa-mir181b-1. We infer that only hsa-
mir181a-1 is co-transcriptionally processed. Evidently, mNET-
seq distinguishes co-transcriptional and post-transcriptional
pre-miRNA processing. We also note that the variable mNET-
seq double peaks (i.e., hsa-mir-27b) and single peaks (i.e.,
hsa-mir-26b) suggest kinetic differences in pre-miRNA biogen-
esis. Some pre-miRNAs (such as pre-miRNA-26b and 181a-1)
may be released immediately from the Pol II elongation complex
after microprocessor cleavage. Other pre-miRNAs (such as pre-
miRNA-27b and let-7g) may be more slowly released with the 30
ends of the pre-miRNA still tethered to the Pol II elongation com-
plex (Figure 5E, model). Significantly, S2P and S5P generally
show larger peaks than unph for pre-miRNA processing, sug-
gesting that CTD phosphorylation is important for co-transcrip-
tional pre-miRNA biogenesis. For theMIR17HG locus containing
six tandem pre-miRNA (Figure S5D), Drosha co-transcriptionally
cleaves the outer pre-miRNA. However, more inner pre-miR18a
and pre-miR19a appear to be processed post-transcriptionally,
as judged by a lack of mNET-seq peaks and the absence of a
hole in the ChrRNA-seq profile over these sequences (Conrad
et al., 2014).
Pol II Pausing Regulated by CPA Factors at TES
To establish the impact of CPA factors on mNET-seq profiles
over and 30 to TES, we depleted CPA (CPSF73 and CstF64+
CstF64t) and Xrn2 by siRNA treatment (Figure S6A, left panels).
ChrRNA-seq analyses for specific genes demonstrated clear
Pol II termination defects after depletion of CPA factors (Fig-
ure S6A, right panels). Double-knockdown of CstF64+CstF64t
proteins was necessary to see a full termination defect, presum-
ably due to their functional redundancy in HeLa cells (Yao et al.,
2012). Xrn2 knockdown showed no significant termination
defect as suggested previously (Brannan et al., 2012). Possibly
like CstF64, this factor acts redundantly with other termination
factors. Interestingly, Xrn2 depletion increased transcript levels534 Cell 161, 526–540, April 23, 2015 ª2015 The Authorswithin the GB, suggesting a major role for Xrn2 in nuclear turn-
over (Davidson et al., 2012). We also performed ChrRNA-seq
analysis for histone genes (Figure S6B). Here, CPSF73 still
showed a clear termination defect consistent with the known
association of CPSF with the histone 30 processing machinery
(Kolev and Steitz, 2005). In contrast, CstF64+CstF64t or Xrn2
knockdowns showed no termination defect. Notably, loss of
Xrn2 significantly increased histone gene reads, again indicating
a major role in histone mRNA turnover.
To extend our termination studies tomNET-seq, we principally
analyzed CTD S2P profiles as these are most likely to show ef-
fects on 30 end processing (Ahn et al., 2004; Hirose and Manley,
1998; McCracken et al., 1997). However, we also performed S5P
and unph meta-analyses in CPSF73-depleted cells. Interest-
ingly, depletion of CPSF73 substantially reduced Pol II unph,
S2P, and S5P pausing over the TES (Figure 6A). Similarly
CstF64+CstF64t double-knockdown reduced TES pausing. In
contrast, Xrn2 knockdown showed no significant difference to
the siLuc control (Figure 6B). We also observe that S2P profiles
upon knockdown of CPA factors crossed over the siLuc control
profile approximately 2.5 kb downstream of the TES, reflecting
expected transcriptional termination defects (Figures 6A and
6B). These mNET-seq meta-analyses were complemented by
ChrRNA-seq (Figure 6C) where meta-analysis of CPSF73 knock-
down gave clear a termination defect immediately following the
TES, whereas CstF64+CstF64t double-knockdown showed a
termination defect further downstream. Again, specific genes
are shown from both our mNET-seq and ChrRNA-seq data
sets and show similar trends to those seen in meta-analyses
after CPA knockdown (Figures S6C and S6D).
30 End Termination Machinery Regulates Levels of
Promoter-Associated RNA
Although RNA cleavage sites have been previously identified
near TSS (Almada et al., 2013), which factors are involved in
this process has not been determined. Because CPSF73 con-
tains the endonuclease activity, it could potentially cleave
nascent RNA near the TSS by recognition of cryptic PAS. We
therefore performed meta-analysis across TSS using the
mNET-seq data obtained from knockdown of CPA factors
and Xrn2. Interestingly, we observe an equivalent increase in
TSS-associated S2P Pol II pausing on both mRNA and PROMPT
strands after depletion of CPA factors and Xrn2 (Figures 7A and
7B). Notably, this effect is specific for S2P as S5P or unph meta-
analysis following CPSF73 knockdown did not show a change in
TSS pausing (Figure 7A). S2P meta-analysis of CstF64+CstF64t
double-knockdown shows an average 3.6-fold increase as
compared to siLuc (Figure 7B, top). Also, CPSF73 and Xrn2
knockdowns both show an average 2.3-fold increase in Pol II
pausing (Figures 7A, middle and 7B, bottom). The extent of
pausing varies with a more focused effect for CPSF73 and
Xrn2 but more prolonged for CstF64+CstF64t on both mRNA
and PROMPT strands (Figures 7A and 7B). We also present
gene-specific examples to validate our TSS mNET-seq meta-
analysis. FUS shows enhanced levels of TSS mNET-seq reads
following CPSF73 knockdown, but only for S2P (Figure 7C).
SLC30A6 also shows similar enhanced levels of TSS reads for
S2P following each termination factor knockdown (Figure 7D).
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(A)Meta-analysis ofmNET-seqwith indicatedPol II antibodies over TES regions (0.5 k+7kb) from siLuc (dark gray) and siCPSF73 (red) treatedHeLa cells (left) is
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Figure 7. Promoter-Associated RNA Turnover Regulated by Termination Factors
(A) Meta-analysis of mNET-seq with indicated Pol II antibodies over TSS regions (0.5k+0.5 kb) from siLuc (dark gray) and siCPSF73 (red) treated HeLa
cells (left).
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(D) mNET-seq/S2P maps with indicated knockdowns around TSS of SLC30A6 on both mRNA and PROMPT strands.
(E) Model showing effects of CPA and Xrn2 at TSS. S2P Pol II-CPA complex (red circle) cleaves TSS-associated nascent RNA, and Xrn2 (purple) degrades
cleaved RNA from 50 end to 30 end over a region of 250 bp from TSS.
For (A) and (B), line and shading represent mean ± SEM for each bin.Wequantitated the effects of termination factor knockdown by
measuring the ratio change between mNET-seq reads over the
TSS as compared to the GB; we refer to this as the Escaping536 Cell 161, 526–540, April 23, 2015 ª2015 The AuthorsIndex (EI). We also calculated any changes in read values across
the GB (Figure S7; Extended Experimental Procedures). The dis-
tribution of EI values clearly shows that depletion of all three
factors increases promoter-associated S2P Pol II pausing but
has no effect on S2P Pol II distribution across the GB. These re-
sults indicate that CPA factors and Xrn2 are involved in restrict-
ing the levels of promoter-associated non-productive
transcripts.
In order to examine whether CPA factors could directly bind to
nascent RNA near TSS, we analyzed in vivo cross-linking and
immunoprecipitation (CLIP) data for genome-wide alternative
polyadenylation at TES (Martin et al., 2012). Surprisingly, all
CPA factors, including CPSF73, CstF64, CstF64t, CPSF160,
CPSF30, and CFIm25 proteins, are significantly detected on
both strands within 500 nt of the TSS. Especially CPSF73 shows
a substantial peak 160 nt upstream and 80 nt downstream of
TSS (Figure S7C and Table S1). Together with our mNET-seq/
S2P results, we conclude that the CPA complex cleaves not
only pre-mRNA at the PAS to promote 30 end termination but
also promotes promoter-associated premature termination (Fig-
ure 7E). Notably, Xrn2 plays a unique role in TSS but not in TES
termination.
DISCUSSION
Our mNET-seq analysis reveals precise maps of both nascent
RNA and the associated Pol II ‘‘CTD code.’’ We employed
recently evaluated high-affinity and specificity monoclonal anti-
bodies to Pol II CTD S5P, S2P, unph, and unph+ph (Figure S2;
Stasevich et al., 2014) in our mNET-seq analysis. Interestingly,
our mNET-seq data reveal significant differences in CTD modifi-
cation profiles across mammalian protein-coding genes as
compared to previous studies. In particular, we detect predom-
inantly low or unphosphorylated CTD over the TSS region (at
least lacking S5P and S2P modification). Furthermore, most de-
tected S5P signal is found in the GBs, where it is particularly
associated with actively spliced exons. Finally, although we
find that S2P signal is more associated with TES regions (consis-
tent with previous studies), we demonstrate a redistribution of
this CTD mark to TSS following CPA depletion. Several explana-
tions may account for the differences between our mNET-seq
data and previous studies. Thus, mNET-seq does not involve
cross-linking (by formaldehyde), which is by necessity used in
ChIP analysis. The possibility that cross-linking distorts the
native chromatin structure remains a concern. Similarly,
mNET-seq detects nascent transcripts at single-nucleotide res-
olution, which cannot be achieved by GRO-seq analysis. Even
though PRO-seq analysis does give single-nucleotide resolution,
the act of isolating nuclei, treating with sarcosyl, and then
carrying out an in vitro transcription reaction (using modified nu-
cleotides) as in both GRO-seq and PRO-seq protocols may
distort the native transcription profiles of genes. Clearly, in the
future, we can extend our analysis to include other CTD phos-
phorylation marks using appropriate Pol II antibodies. For
example, the CTD S7P mark is important to recruit Integrator
complex to snRNA genes, which regulates 30 end processing
and termination (Egloff et al., 2007). Mutation of CTD T4 specif-
ically represses histone gene expression by blocking 30 end
processing (Hsin et al., 2011). Another CTD modification, Y1P,
stimulates the binding of elongation factor Spt6 and blocks
recruitment of termination factors in yeast (Mayer et al., 2012).It remains a possibility that the mammalian CTD code may be
significantly different than the likely simplified code for budding
yeast. Notably, yeast CTD has only 26 heptad repeats in its
CTD, and these are near identical, unlike the more variable
mammalian heptad repeats. Possibly, the high S5P TSS signals
observed in yeast are replaced by other CTD or indeed histone
marks in higher eukaryotes. Furthermore, few yeast genes
possess introns so that the dominant presence of S5P marks
over mammalian exons would be less quantitatively significant
in yeast. Even so, it has been shown that yeast introns display
high S5P signals near their 30 ends (Alexander et al., 2010), simi-
larly to themammalian S5P splicing association, described here.
A remarkable feature of our mNET-seq data is that we readily
detect RNA 30 ends formed as RNA-processing intermediates
through co-association of RNA-processing complexes with
elongating Pol II. In particular, the Pol II CTD S5P mark, previ-
ously thought to be mainly associated with TSS events such as
co-transcriptional capping and early transcriptional elongation
(Hsin and Manley, 2012), plays a major role in splicing. Thus,
50SS peaks of mNET-seq/S5P are detected at the end of co-
transcriptionally spliced exons (Figure 3), indicating that the 30
cleaved upstream exon within the spliceosome is associated
with Pol II elongation complexes in an S5P-dependent manner.
We also note that the mNET-seq S5P reads are particularly
high over spliced exons, suggesting that S5P Pol II pauses
over functional exons allowing time for U2 snRNP-mediated acti-
vation of 50SS cleavage. Indeed, we demonstrate this by directly
inhibiting U2 snRNP function (Figures 4 and S4). Overall, we find
that the 50SS cleavage intermediate is retained within the spli-
ceosome C complex associated with Pol II S5P until subsequent
ligation with the downstream exon can occur (Figure 4D, model).
In effect, we provide genome-wide support for exon tethering to
Pol II as previously predicted from studies on transfected gene
constructs wherein co-transcriptional intron cleavage did not
prevent exon splicing across a discontinuous intron (Dye et al.,
2006). We anticipate that our mNET-seq technology will provide
new ways to unravel the complexity of the co-transcriptional
splicing mechanism.
A surprising aspect of our mNET-seq analysis is that we do not
detect a peak of signal associated with pre-mRNA 30 end pro-
cessing (TES meta-analysis in Figure 2C and Figures 6A and
6B). This contrasts the splicing-associated 50SS and Drosha
cleavage sites that are highly prevalent in our data (Figures 3,
4, and 5). We predict that 30 end cleavage (coupled with polyade-
nylation) may cause rapid mRNA release from the Pol II complex
and so escape mNET-seq detection, like in the pre-miRNA fast-
release model (Figure 5E). Although 30 end processing is known
to be required for Pol II termination (Proudfoot, 2011), it is also
thought that Pol II pausing at TES regulates both 30 end process-
ing and subsequent transcription termination (Gromak et al.,
2006; Nag et al., 2007). We examined the effect on Pol II pausing
at TES following depletion of CPA components. Consistent with
previous reports, ChrRNA-seq reveals that CPSF73 and CstF64
depletion cause transcriptional termination defects on protein-
coding genes (Figure 6). Interestingly, our mNET-seq data also
reveal that depletion of CPA factors causes significantly less
pausing immediately downstream of TES (<3 kb from TES) and
then more Pol II occupancy at further downstream regionsCell 161, 526–540, April 23, 2015 ª2015 The Authors 537
(>3 kb from TES) compared to control cells. This indicates that
Pol II elongation speed is regulated by the CPA complex, which
may be an important factor inmediating transcription termination
(Figure 6D). We also demonstrate that no significant termination
defect occurs following the TES upon knockdown of Xrn2 (Fig-
ure 6A, bottom). This observation contrasts our previous reports
based on plasmid transfection studies (West et al., 2004). How-
ever, it has been shown more recently that Xrn2 has a required
partner protein, TTF2, for transcription termination (Brannan
et al., 2012). It seems likely that Xrn2-associated termination is
redundant with other termination factors.
Unexpectedly, mNET-seq analysis showed a significant in-
crease specifically in S2P Pol II pausing at the TSS (<250
base) for both mRNA and PROMPT transcription upon CPA fac-
tor and Xrn2 depletion. This suggests that CPA and Xrn2 are
involved in premature termination at the TSS, consistent with
a previous report (Brannan et al., 2012). Although CPA factors
and Xrn2 affect S2P Pol II occupancy at TSS, they show no dif-
ference in S2P Pol II distribution across the GB. Recent studies
have pointed toward differences between promoter-proximal
termination for mRNA sense or antisense RNA (Almada et al.,
2013; Ntini et al., 2013). Antisense TSS transcripts (PROMPTs)
are thought to utilize cryptic PAS close to the TSS, whereas
sense TSS transcripts may have reduced occurrence of cryptic
PAS. Those that are present may be blocked by nearby 50SS U1
snRNP recruitment (Kaida et al., 2010). These apparent differ-
ences in cryptic PAS usage between PROMPTs and sense
TSS-associated transcripts may favor productive sense over
non-productive antisense transcription. However, our mNET-
seq data suggest that CPA factors and Xrn2 play equivalent
roles in restricting sense and antisense TSS transcription.
Thus, their depletion causes an equivalent increase in S2P
Pol II pausing in both transcriptional directions. Also, we show
by CLIP analysis that CPA factors are directly and equally asso-
ciated with these two transcript classes (Martin et al., 2012). Our
data suggest that transcriptional directionality at TSS is unlikely
to be regulated by CPA-mediated termination. Rather both
sense and antisense TSS-associated transcripts are restricted
by normally TES-associated termination factors. Indeed, we
observe a redistribution of S2P Pol II from the TES to the TSS
following CPA factor and Xrn2 knockdown. This argues for close
interconnections between both ends of the Pol II transcription
unit, as previously demonstrated by 3C analysis (Ansari and
Hampsey, 2005; O’Sullivan et al., 2004; Tan-Wong et al.,
2012). Several gene-specific analyses in mammals have re-
ported the co-association of CPA with transcription initiation
factors. Thus, CPSF is a known component of some TFIID com-
plexes (Dantonel et al., 1997), and CstF has been shown to
associate with TFIIB (Wang et al., 2010). Also, mutating the
PAS depleted promoter-associated transcription factors and
increased promoter-associated Pol II CTD S2P (Mapendano
et al., 2010). Finally, the elongation factor TFIIS has been shown
to promote release of paused TSS transcripts in Drosophila
(Adelman et al., 2005), and this may in turn relate to CPA pro-
moter effects.
Overall, mNET-seq maps nascent transcription at single-
nucleotide resolution, showing both Pol II pausing and associ-
ated co-transcriptional RNA cleavage. Importantly, this method538 Cell 161, 526–540, April 23, 2015 ª2015 The Authorscan be applied genome wide to check for modified polymerase
occupancy (even Pol I and Pol III) by selecting a range of different
antibodies. We anticipate that mNET-seq will expand our knowl-
edge of how different nascent RNA are associated with specific
‘‘CTD codes.’’
EXPERIMENTAL PROCEDURES
Antibodies and siRNA
Antibodies and siRNA information are available in the Extended Experimental
Procedures. In outline, siRNA treatment was carried out for 3 days prior to cell
harvesting. The efficiency of protein depletion was confirmed by western blot
with appropriate antibodies.
Cell Culture, NRO Assay, and RT-PCR
Cell culture and NRO assay were as previously described (Nojima et al.,
2013). RT-PCR and primers are described in the Extended Experimental
Procedures.
In Vivo Splicing Inhibition
HeLa cells were treated with either DMSO (0.1%) or Pla-B (1 mM) for 4 hr. Pla-B
was purchased from Santa Cruz (sc-391691).
RNA-Seq Methods
Preparation of chromatin and nucleoplasmic RNA was previously described
(Nojima et al., 2013). For mNET-seq, isolated chromatin was incubated with
MNase (40 u/ml). MNase was inactivated by EGTA, and the insoluble chromatin
removed by centrifugation. IP was performed from the supernatant using spe-
cific Pol II antibody-conjugated beads for 1 hr. IPed RNAwas 50 end phosphor-
ylated by polynucleotide kinase treatment of the washed beads. Purified RNA
was fractionated on denaturing acrylamide gels, and a 35–100 nt fraction was
isolated. RNA libraries were prepared according to the manual of Truseq small
RNA library prep kit (Illumina). The reads were generated in Hiseq2000/2500
(Illumina). For full methods, see the Extended Experimental Procedures.
Data Pre-Processing
mNET-seq data adaptors were trimmed using Cutadapt (v1.1) (Martin, 2011).
The remaining paired reads were aligned to the reference human genome
(hg19) using TopHat (v2.0.9) (Kim et al., 2013) only allowing for one alignment
to the reference. The last nucleotide incorporated by the polymerase was
defined as the 50 end of read two (green arrow, Figure 1A) of the pair, with
the directionality indicated by read one (blue arrow, Figure 1A), and then the
properly aligned read pairs were trimmed to solely keep the 50 nucleotide of
read two. ChrRNA-seq and nucleoplasm RNA-seq data were aligned using
the same version of TopHat but allowing for the read pairs to be separated
by 3 kb. Further details of data pre-processing and bioinfomatic analysis are
available in the Extended Experimental Procedures.
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